Defects in homologous recombination repair (HR) genes used to repair double-strand breaks, e.g., mutations in BRCA1, BRCA2, and RAD51, lead to HR deficiency (HRD), and confer sensitivity to PARP inhibition. Here, BRCA2 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.